Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 11, Pages 8154-8162
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-01-21
DOI
10.1074/jbc.m111.308601
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
- (2011) Holger Cynis et al. EMBO Molecular Medicine
- Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease
- (2011) Sadim Jawhar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective Hippocampal Neurodegeneration in Transgenic Mice Expressing Small Amounts of Truncated A Is Induced by Pyroglutamate-A Formation
- (2011) A. Alexandru et al. JOURNAL OF NEUROSCIENCE
- Potent amyloidogenicity and pathogenicity of Aβ43
- (2011) Takashi Saito et al. NATURE NEUROSCIENCE
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease
- (2010) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease
- (2010) Oliver Wirths et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice
- (2010) Sadim Jawhar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease
- (2010) Sadim Jawhar et al. NEUROBIOLOGY OF AGING
- Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network
- (2010) Julie A. Harris et al. NEURON
- Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
- (2009) Oliver Wirths et al. ACTA NEUROPATHOLOGICA
- Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
- (2009) Dagmar Schlenzig et al. BIOCHEMISTRY
- Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
- (2009) Oliver Wirths et al. JOURNAL OF NEURAL TRANSMISSION
- Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains
- (2009) Hedvig Welander et al. JOURNAL OF NEUROCHEMISTRY
- Aminopeptidase A contributes to the N-terminal truncation of amyloid β-peptide
- (2009) Jean Sevalle et al. JOURNAL OF NEUROCHEMISTRY
- Effects of γ-Secretase Inhibition on the Amyloid β Isoform Pattern in a Mouse Model of Alzheimer’s Disease
- (2009) Erik Portelius et al. Neurodegenerative Diseases
- Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice
- (2008) Ditte Zerlang Christensen et al. ACTA NEUROPATHOLOGICA
- Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
- (2008) Stephan Schilling et al. NATURE MEDICINE
- Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease
- (2008) Ditte Z. Christensen et al. NEUROBIOLOGY OF AGING
- Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease
- (2007) Oliver Wirths et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started